Long Noncoding RNA CDKN2B-AS1 Facilitates Lung Cancer Development Through Regulating miR-378b/NR2C2

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• Long noncoding RNAs (lncRNAs) are critical regulators in disease pathogenesis.
• CDKN2B-AS1 is a newly identified tumor-related lncRNA with known roles in other cancers.
• The specific function and mechanism of CDKN2B-AS1 in lung cancer remain largely unexplored.

Purpose of the Study:

• To investigate the role and underlying mechanism of lncRNA CDKN2B-AS1 in lung cancer.
• To determine the relationship between CDKN2B-AS1, miR-378b, and NR2C2 in lung cancer progression.

Main Methods:

• Assessed cell proliferation, invasion, migration, and apoptosis using CCK-8, Transwell assays, and Western blot.
• Employed bioinformatics analysis to predict CDKN2B-AS1 targets.
• Conducted rescue experiments to elucidate the functional interplay between CDKN2B-AS1 and miR-378b.

Main Results:

• CDKN2B-AS1 expression was significantly upregulated in lung cancer tissues and cell lines.
• Overexpression of CDKN2B-AS1 enhanced proliferation and invasion while reducing apoptosis; knockdown showed opposite effects.
• Bioinformatics and rescue experiments confirmed CDKN2B-AS1 targets miR-378b, which in turn targets NR2C2; both miR-378b and NR2C2 were upregulated in lung cancer.

Conclusions:

• CDKN2B-AS1 promotes lung cancer development by modulating the miR-378b/NR2C2 axis.
• This study elucidates a novel mechanism for CDKN2B-AS1 in lung cancer.
• CDKN2B-AS1 represents a potential therapeutic target for lung cancer intervention.